Preliminary Study of the Cytotoxic Activity of Pd(II) and Pt(II) Complexes Bearing P-N ligands Derived from Aminoalcohols
Authors:
- Jair Isai Ortega-GaxiolaJOJair Isai Ortega-Gaxiola
- Juan S. Serrano-GarcíaJuan S. Serrano-García
- Andrés Amaya-FlórezAAAndrés Amaya-Flórez
- Jordi R. GalindoJGJordi R. Galindo
- Antonino Arenaza-CoronaAAAntonino Arenaza-Corona
- Simón Hernández-OrtegaSHSimón Hernández-Ortega
- Teresa Ramírez-ApanTRTeresa Ramírez-Apan
- Jorge Alí-TorresJAJorge Alí-Torres
- Adrián L. OrjuelaAOAdrián L. Orjuela
- Viviana Reyes-MárquezViviana Reyes-Márquez
- Michelle Acosta-EncinasMAMichelle Acosta-Encinas
- Raúl Colorado-PeraltaRCRaúl Colorado-Peralta
Open Access
- 2 December 2025
- journal article
- research article
- Published by MDPI AG in Inorganics
- Vol. 13 (12) , 398
Abstract
Iminophosphine ligands find extensive applications in homogeneous catalysis; however, their potential antitumor activity is currently being explored. Including biologically active moieties, such as aminoalcohols, could enhance this activity further. Therefore, we have synthesised a novel series of Pd(II) and Pt(II) iminophosphine complexes incorporating aminoalcohols as biologically active moieties to explore the potential of enhancing this activity. The series of Pd(II) complexes includes complexes 2a, 2f, and 2h, which were previously reported by our research group as catalysts in Suzuki–Miyaura cross-coupling reaction in aqueous media. Besides their complete characterisation, some structures have been unequivocally corroborated by single-crystal X-ray diffraction (SC-XRD). To evaluate the cytotoxic potential of the complexes, a preliminary in vitro study was conducted on different cancerous cell lines, including using COS-7 cells as a healthy cell line. Notably, complexes 2e, 2f, and 3b exhibited selectivity towards human chronic myelogenous leukaemia (K562), demonstrating IC50 values of 7.73 ± 1.4 µM, 8.53 ± 1.9 µM, and 8.83 ± 1.5 µM, respectively. Remarkably, the selectivity of these complexes surpassed that of cisplatin. Furthermore, in silico analysis indicated a higher binding energy of these complexes to DNA when compared to cisplatin.Keywords
Funding Information
- PAPIIT-DGAPA-UNAM (IN223323)
- Secretaría de Ciencia, Tecnología e Innovación del Distrito Federal (A1-S-033933)
This publication has 50 references indexed in Scilit:
- Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistanceRare Metals, 2024
- Transition Metal Complexes with Tridentate Schiff Bases (O N O and O N N) Derived from Salicylaldehyde: An Analysis of Their Potential Anticancer ActivityChemMedChem, 2022
- Relevance of Using Platinum-Containing Antitumor Compounds (A Review)Pharmaceutical Chemistry Journal, 2022
- Role of Platinums in Triple-Negative Breast CancerCurrent Oncology Reports, 2021
- Palladium complexes: new candidates for anti-cancer drugsJournal of the Iranian Chemical Society, 2016
- Synthesis, characterisation and in vitro evaluation of palladium(II) iminophosphine complexes for anticancer activityTransition Metal Chemistry, 2012
- Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylationActa Biomaterialia, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Iterative partial equalization of orbital electronegativity—a rapid access to atomic chargesTetrahedron, 1980